ByungKun Lee1, WooJhon Choi1, Jonathan J Liu1, Chen D Lu1, Joel S Schuman2, Gadi Wollstein2, Jay S Duker3, Nadia K Waheed3, James G Fujimoto1. 1. Department of Electrical Engineering and Computer Science and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States. 2. UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States. 3. New England Eye Center, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, United States.
Abstract
PURPOSE: To develop and demonstrate a cardiac gating method for repeatable in vivo measurement of total retinal blood flow (TRBF) in humans using en face Doppler optical coherence tomography (OCT) at commercially available imaging speeds. METHODS: A prototype swept-source OCT system operating at 100-kHz axial scan rate was developed and interfaced with a pulse oximeter. Using the plethysmogram measured from the earlobe, Doppler OCT imaging of a 1.5- × 2-mm area at the optic disc at 1.8 volumes/s was synchronized to cardiac cycle to improve sampling of pulsatile blood flow. Postprocessing algorithms were developed to achieve fully automatic calculation of TRBF. We evaluated the repeatability of en face Doppler OCT measurement of TRBF in 10 healthy young subjects using three methods: measurement at 100 kHz with asynchronous acquisition, measurement at 100 kHz with cardiac-gated acquisition, and a control measurement using a 400-kHz instrument with asynchronous acquisition. RESULTS: The median intrasubject coefficients of variation (COV) of the three methods were 8.0%, 4.9%, and 6.1%, respectively. All three methods correlated well, without a significant bias. Mean TRBF measured at 100 kHz with cardiac-gated acquisition was 40.5 ± 8.2 μL/min, and the range was from 26.6 to 55.8 μL/min. CONCLUSIONS: Cardiac-gated en face Doppler OCT can achieve smaller measurement variability than previously reported methods. Although further validation in older subjects and diseased subjects is required, precise measurement of TRBF using cardiac-gated en face Doppler OCT at commercially available imaging speeds should be feasible.
PURPOSE: To develop and demonstrate a cardiac gating method for repeatable in vivo measurement of total retinal blood flow (TRBF) in humans using en face Doppler optical coherence tomography (OCT) at commercially available imaging speeds. METHODS: A prototype swept-source OCT system operating at 100-kHz axial scan rate was developed and interfaced with a pulse oximeter. Using the plethysmogram measured from the earlobe, Doppler OCT imaging of a 1.5- × 2-mm area at the optic disc at 1.8 volumes/s was synchronized to cardiac cycle to improve sampling of pulsatile blood flow. Postprocessing algorithms were developed to achieve fully automatic calculation of TRBF. We evaluated the repeatability of en face Doppler OCT measurement of TRBF in 10 healthy young subjects using three methods: measurement at 100 kHz with asynchronous acquisition, measurement at 100 kHz with cardiac-gated acquisition, and a control measurement using a 400-kHz instrument with asynchronous acquisition. RESULTS: The median intrasubject coefficients of variation (COV) of the three methods were 8.0%, 4.9%, and 6.1%, respectively. All three methods correlated well, without a significant bias. Mean TRBF measured at 100 kHz with cardiac-gated acquisition was 40.5 ± 8.2 μL/min, and the range was from 26.6 to 55.8 μL/min. CONCLUSIONS: Cardiac-gated en face Doppler OCT can achieve smaller measurement variability than previously reported methods. Although further validation in older subjects and diseased subjects is required, precise measurement of TRBF using cardiac-gated en face Doppler OCT at commercially available imaging speeds should be feasible.
Authors: G T Feke; S M Buzney; H Ogasawara; N Fujio; D G Goger; N P Spack; K H Gabbay Journal: Invest Ophthalmol Vis Sci Date: 1994-06 Impact factor: 4.799
Authors: S E Bursell; A C Clermont; B T Kinsley; D C Simonson; L M Aiello; H A Wolpert Journal: Invest Ophthalmol Vis Sci Date: 1996-04 Impact factor: 4.799
Authors: Alex D Pechauer; Thomas S Hwang; Ahmed M Hagag; Liang Liu; Ou Tan; Xinbo Zhang; Maria Parker; David Huang; David J Wilson; Yali Jia Journal: Br J Ophthalmol Date: 2017-05-11 Impact factor: 4.638
Authors: Alex D Pechauer; Ou Tan; Liang Liu; Yali Jia; Vivian Hou; William Hills; David Huang Journal: Invest Ophthalmol Vis Sci Date: 2016-07-01 Impact factor: 4.799
Authors: Mahnaz Shahidi; Anthony E Felder; Ou Tan; Norman P Blair; David Huang Journal: Invest Ophthalmol Vis Sci Date: 2018-04-01 Impact factor: 4.799
Authors: ByungKun Lee; Eduardo A Novais; Nadia K Waheed; Mehreen Adhi; Talisa E de Carlo; Emily D Cole; Eric M Moult; WooJhon Choi; Mark Lane; Caroline R Baumal; Jay S Duker; James G Fujimoto Journal: JAMA Ophthalmol Date: 2017-03-01 Impact factor: 7.389
Authors: Katarzyna J Witkowska; Ahmed M Bata; Giacomo Calzetti; Nikolaus Luft; Klemens Fondi; Piotr A Wozniak; Doreen Schmidl; Matthias Bolz; Alina Popa-Cherecheanu; René M Werkmeister; Gerhard Garhöfer; Leopold Schmetterer Journal: PLoS One Date: 2017-09-12 Impact factor: 3.240
Authors: Stephan Szegedi; Nikolaus Hommer; Martin Kallab; Stefan Puchner; Doreen Schmidl; René M Werkmeister; Gerhard Garhöfer; Leopold Schmetterer Journal: Transl Vis Sci Technol Date: 2020-06-25 Impact factor: 3.283